Poster Abstract Session:
218. Clinical Infectious Diseases: Osteomyelitis
Saturday, October 10, 2015: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:


Tracks: Pediatric ID, Adult ID

Impact of Methicillin-Resistant Staphylococcus aureus in Osteomyelitis and Soft Tissue Infections of the Foot
Chester Ashong, PharmD ; Shazia Raheem, PharmD ; Andrew Hunter, PharmD ; Neal Barshes, MD, MPH
Impact of a Pediatric Evidence-Based Acute Hematogenous Osteomyelitis Diagnostic and Treatment Algorithm
Rachel Quick, RN, MSN, CNS ; Patrick Boswell, BA ; Kathryn Merkel, PharmD, BCPS, AQ ID ; Marisol Fernandez, MD ; Lynn Thoreson, DO ; John Williams, MD ; Sarmistha Hauger, MD
  • IDSA Osteo Poster FINAL.pdf (571.6 kB)
  • Osteomyelitis after Open Fractures Adjusting  Prophylactic Antimicrobial Therapy
    Kamla Sanasi-Bhola, MD ; Majdi Al-Hasan, MD ; Sharon Weissman, MD ; Helmut Albrecht, MD ; Rebecca Berdel, MD ; Stephan Albrecht, BS ; Medha Iyer, M.D., Ph.D. ; Joseph Horvath, MD
    The Clinical Utility of PET Scans for Evaluation of Osteomyelitis: Do Results Actually Impact Management?
    Natalie Uy, BS, BA ; Shahriar Tavakoli-Tabasi, MD ; Luis Tamara, MD ; Daniel Musher, MD, FIDSA
    Correlation of Magnetic Resonance Imaging Findings With Pathologic Evidence of Osteomyelitis in (Clinical) Practice
    Veenu Gill, M.D. ; Jorg Ruhe, M.D. ; Donna Mildvan, M.D. ; David C. Perlman, MD
    Lack of effect of recent antibiotics on results of vertebral biopsy cultures in patients with vertebral infections
    Vladimir Labalo, MD ; Louis Saravolatz II, BS ; Joel Fishbain, MD, FIDSA ; Susan Szpunar, PhD ; Leonard B Johnson, MD, FIDSA
  • Labalo poster ID week.pdf (644.1 kB)
  • A Comparative Study of Tuberculous and Culture-Negative Pyogenic Spondylitis
    Chung-Jong Kim, MD ; Kyoung-Ho Song, MD ; Pyoeng Gyun Choe, MD ; Wan Beom Park, MD, PhD ; Ji Whan Bang, MD ; Eu Suk Kim, MD ; Sang-Won Park, MD, PhD ; Hong-Bin Kim, MD ; Myoung-Don Oh, MD, PhD ; Nam Joong Kim, MD, PhD
    Comparison of Outcomes of Patients with Spinal Epidural Infection without Neurologic Deficit According to the Initial Treatment Plan
    Chung-Jong Kim, MD ; Seung-Ji Kang, MD ; Kyoung-Ho Song, MD ; Wan Beom Park, MD, PhD ; Joon Woo Lee, MD PhD ; Sung Hwan Hong, MD PhD ; Seung Jin Lee, MD ; Eu Suk Kim, MD ; Sang-Won Park, MD, PhD ; Hong Bin Kim, MD, PhD ; Myoung-Don Oh, MD, PhD ; Kyung Hwa Park, MD ; Nam Joong Kim, MD, PhD
    Successful Management of Osteomyelitis in Infectious Disease Physician Office Infusion Centers (POICs)
    John S. Adams, MD, FIDSA, FSHEA ; Richard C. Prokesch, MD, FACP, FIDSA ; Robin H. Dretler, MD, FIDSA ; Brian Metzger, MD, MPH ; Quyen Luu, MD ; Andrew H. Krinsky, MD ; Claudia P. Schroeder, PharmD, PhD ; Lucinda J. Van Anglen, PharmD
    A Pilot Study Evaluating Telavancin for the Treatment of Methicillin-Resistant Staphylococcus aureus Osteomyelitis: Clinical Outcomes and Safety
    Julie Harting, PharmD ; Francisco Fernandez, MD ; Robert Kelley, PhD ; Timothy L. Wiemken, PhD, MPH, CIC ; Paula Peyrani, MD ; Julio a. Ramirez, MD, FIDSA

    CME Credits:

    ACPE Credits:

    ACPE Number:

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.